GAIL MCWHIRTER: Open Payments
NPI 1063763340 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 26 payments from 8 companies in 2025. Trend: 2023 $730 · 2024 $625 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $219 |
| Supernus Pharmaceuticals, Inc. | 6 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: FANAPT, Qelbree, TRINTELLIX, CAPLYTA, COBENFY, INGREZZA, Jornay PM, Auvelity.
Industry payments across FL — which companies pay providers there.
